Department of Psychosis Studies,King's College London, Institute of Psychiatry,De Crespigny Park, London, SE5 8AF,UK.
Department of Psychology,University of Roehampton,UK.
Psychol Med. 2018 Dec;48(16):2748-2756. doi: 10.1017/S0033291718000387. Epub 2018 Mar 5.
Cannabis and its main psychoactive ingredient δ-9-tetrahydrocannibidiol (THC) can induce transient psychotic symptoms in healthy individuals and exacerbate them in those with established psychosis. However, not everyone experience these effects, suggesting that certain individuals are particularly susceptible. The neural basis of this sensitivity to the psychotomimetic effects of THC is unclear.
We investigated whether individuals who are sensitive to the psychotomimetic effects of THC (TP) under experimental conditions would show differential hippocampal activation compared with those who are not (NP). We studied 36 healthy males under identical conditions under the influence of placebo or THC (10 mg) given orally, on two separate occasions, in a pseudo-randomized, double-blind, repeated measures, within-subject, cross-over design, using psychopathological assessments and functional MRI while they performed a verbal learning task. They were classified into those who experienced transient psychotic symptoms (TP; n = 14) following THC administration and those who did not (NP; n = 22).
Under placebo conditions, there was significantly greater engagement of the left hippocampus (p < 0.001) in the TP group compared with the NP group during verbal encoding, which survived leave-one-out analysis. The level of hippocampal activation was directly correlated (Spearman's ρ = 0.44, p = 0.008) with the severity of transient psychotic symptoms induced by THC. This difference was not present when we compared two subgroups from the same sample that were defined by sensitivity to anxiogenic effects of THC.
These results suggest that altered hippocampal activation during verbal encoding may serve as a marker of sensitivity to the acute psychotomimetic effects of THC.
大麻及其主要精神活性成分 δ-9-四氢大麻酚(THC)可在健康个体中诱发短暂的精神病症状,并在已确诊精神病的个体中加重这些症状。然而,并非每个人都有这种体验,这表明某些个体特别容易受到影响。这种对 THC 致幻作用的敏感性的神经基础尚不清楚。
我们研究了在实验条件下对 THC 的致幻作用敏感的个体(TP)与不敏感的个体(NP)相比,其海马体激活是否存在差异。我们在相同条件下,在口服给予安慰剂或 THC(10mg)的两种情况下,对 36 名健康男性进行了研究,采用双盲、随机、重复测量、自身对照、交叉设计,同时进行心理病理学评估和功能磁共振成像,在进行言语学习任务时进行。他们被分为两组:在接受 THC 后出现短暂精神病症状的个体(TP;n=14)和未出现症状的个体(NP;n=22)。
在安慰剂条件下,TP 组在言语编码期间左海马体的激活显著增加(p<0.001),这一结果在单样本外分析中仍然存在。海马体的激活水平与 THC 引起的短暂精神病症状的严重程度直接相关(Spearman's ρ=0.44,p=0.008)。当我们比较来自同一样本的两个对 THC 焦虑作用敏感程度不同的亚组时,这种差异并不存在。
这些结果表明,言语编码期间海马体激活的改变可能是对 THC 急性致幻作用敏感性的标志物。